Search
Blog Post
Cancer Innovations: Prioritizing quality of life while treating cancer
… the Cell Stress and Biophysical Therapy Program, and Emese Zsiros, MD, PhD, FACOG , Director of Research in the … more — and better quality — time with their loved ones Dr. Zsiros has spent the past several years researching the use … was 8-15%. The combination has a synergistic effect,” Dr. Zsiros says. “The typical treatments for ovarian cancer …
News
Roswell Park Team Assesses Addition of Complement Inhibitor Drug to Immunotherapy for Ovarian Cancer
… it has been evaluated for the treatment of cancer. Emese Zsiros, MD, PhD, FACOG , serves as principal investigator for … Research Project Grant (R01) awarded to Drs. Zsiros and Segal. “The tumor microenvironment of ovarian … cancer strongly suppresses the immune system,” says Dr. Zsiros, who is Chair of the Department of Gynecologic …
News
Roswell Park Researchers Uncover Clues to Immunotherapy Response in Patients with Recurrent Ovarian Cancer
… which grew out of a phase 2 clinical trial led by Emese Zsiros, MD, PhD, FACOG , Chair and Director of Research, … can quickly age a patient’s immune system,” explains Dr. Zsiros, a gynecologic oncologist and senior author on the new … due to the weakened state of patients’ immune systems. Dr. Zsiros and team hypothesized that the varied responses …
Blog Post
Cancer Innovations: New initiative reduced prescribed opioids by 45%
… recovery. How would patients fare without opioids? Emese Zsiros, MD, PhD, FACOG, a gynecologic oncologist at Roswell … based on their clinical experience. The results? Dr. Zsiros says the number of opioids prescribed to these … in the fight against the ongoing opioid epidemic.” Dr. Zsiros and her team reported the results from the first six …
Cancer Types
Recurrent Ovarian Cancer
Clinical Trial
A Phase I First-In-Human, Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors
… SIM0505 in Adult Participants with Advanced Solid Tumors I Zsiros, Emese This is an open-label, multicenter phase 1 …
Clinical Trial
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
… MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS I Zsiros, Emese This is an open-label, phase 1, dose escalation …
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Clinical Trials
… contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase … contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase …
Page with Layout
Faculty Mentors
… Sai Yendamuri, MD, MBA, FACS Thoracic Surgery Emese Zsiros, MD, PhD, FACOG Gynecologic Oncology Oncology …
Cancer Types
Immunotherapy for Ovarian Cancer
… infused back into the patient. Become a patient Dr. Emese Zsiros explains some of the current clinical trials at …